Cyclic Sulfonamide RNR Inhibitors for Cancer Treatment
Summary
The USPTO has published a new patent application, US20260085067A1, detailing cyclic sulfonamide RNR inhibitors for cancer treatment. The application was filed on September 12, 2023, by inventors Anthony B. Pinkerton, Jacques Mauger, and Yen Pham Hong Truong.
What changed
This document is a publication of a patent application (US20260085067A1) filed with the USPTO. It describes compounds and methods for treating cancer using cyclic sulfonamide ribonucleotide reductase (RNR) inhibitors. The application was filed on September 12, 2023, and lists Anthony B. Pinkerton, Jacques Mauger, and Yen Pham Hong Truong as inventors.
As this is a patent application, it does not impose immediate regulatory obligations or compliance deadlines on entities. However, it signals potential future intellectual property developments in cancer therapeutics. Companies involved in drug discovery and development, particularly in oncology, should be aware of this filing for competitive intelligence and potential licensing opportunities.
Archived snapshot
Mar 26, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
CYCLIC SULFONAMIDE RIBONUCLEOTIDE REDUCTASE (RNR) INHIBITORS AND USES THEREOF
Application US20260085067A1 Kind: A1 Mar 26, 2026
Inventors
Anthony B. PINKERTON, Jacques MAUGER, Yen Pham Hong TRUONG
Abstract
Provided herein are compounds and methods for the treatment of cancer. The methods include administering to a subject in need a therapeutically effective amount of a cyclic sulfonamide RNR inhibitor disclosed herein.
CPC Classifications
C07D 417/06 A61K 31/5415 A61K 31/549 A61K 31/554 A61P 35/00 C07B 59/002 C07D 417/14 C07D 419/06 C07D 513/04 C07D 515/04
Filing Date
2023-09-12
Application No.
19110333
Named provisions
Related changes
Get daily alerts for USPTO Patent Applications - Organic Chemistry (C07D)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Organic Chemistry (C07D) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.